NYSEAMERICAN:KNW Know Labs (KNW) Stock Price, News & Analysis → the most reliable asset on earth is making a comeback (From DTI) (Ad) Free KNW Stock Alerts $0.63 -0.01 (-1.25%) (As of 05:21 PM ET) Add Compare Share Share Today's Range$0.62▼$0.6450-Day Range N/A52-Week Range$0.23▼$1.48Volume28,308 shsAverage Volume141,135 shsMarket Capitalization$51.25 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsHeadlinesInsider TradesOwnershipShort InterestStock AnalysisChartEarningsHeadlinesInsider TradesOwnershipShort Interest Get Know Labs alerts: Email Address Ad Crypto 101 MediaAltcoin FRENZY Alert…Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days… Click here now to register for the event (FOR FREE!) About Know Labs Stock (NYSEAMERICAN:KNW)Know Labs, Inc., together with its subsidiaries, focuses on the development and commercialization of proprietary sensor technology by radio and microwave spectroscopy in the United States. The company's proprietary platform technologies include ChromaID and Bio-RFID technologies that utilizes electromagnetic energy to detect, record, identify, and measure the signature of said materials or analytes. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was incorporated in 1998 and is based in Seattle, Washington.Read More KNW Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart KNW Stock News HeadlinesMarch 8, 2024 | stockhouse.comKnow Labs' Non-Invasive Glucose Monitor Achieves 11.1% MARD in Latest Clinical Research StudyMarch 6, 2024 | finance.yahoo.comKnow Labs’ Non-Invasive Glucose Monitor Achieves 11.1% MARD in Latest Clinical Research StudyMarch 28, 2024 | WealthPress (Ad)$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…March 2, 2024 | uk.investing.comKnow Labs secures $12 million investment from LindFebruary 29, 2024 | msn.comKnow Labs secures $12M funding for further execution on clinical research and development initiativesFebruary 29, 2024 | finance.yahoo.comKnow Labs Secures U.S. $12 Million Funding for Company’s Further Execution on Its Clinical Research and Development InitiativesFebruary 29, 2024 | businesswire.comKnow Labs Secures U.S. $12 Million Funding for Company's Further Execution on Its Clinical Research and Development InitiativesFebruary 27, 2024 | stockhouse.comKnow Labs Announces the KnowU(TM), its Wearable Non-Invasive Continuous Glucose MonitorMarch 28, 2024 | DTI (Ad)How you can target big results without spending big money!While most folks are paying $500… $1,000… Or even MORE to trade popular stocks like Apple, Nvidia, or Microsoft… I’ve discovered a new way to tap into what could be the cheapest options on the market… I’m talking about the $0.25 Cent Trades! February 27, 2024 | businesswire.comKnow Labs Announces the KnowU™, its Wearable Non-Invasive Continuous Glucose MonitorFebruary 15, 2024 | msn.comKnow Labs, Inc. (NYSE:KNW) Q1 2024 Earnings Call TranscriptFebruary 14, 2024 | finance.yahoo.comKnow Labs, Inc. Reports First Quarter FY2024 ResultsFebruary 14, 2024 | businesswire.comKnow Labs, Inc. Reports First Quarter FY2024 ResultsFebruary 7, 2024 | finance.yahoo.comKnow Labs, Inc. to Host Review of First Quarter Fiscal Year 2024 Results on February 14, 2024February 5, 2024 | msn.comWestern North Carolina lab begins testing for 'gas station heroin' on the heels of FDA warningJanuary 24, 2024 | msn.comCity of Reedley, Fresno County to receive $260K for illegal lab cleanupJanuary 23, 2024 | finance.yahoo.comKnow Labs to Exhibit at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)December 21, 2023 | finance.yahoo.comKnow Labs, Inc. (NYSE:KNW) Q4 2023 Earnings Call TranscriptDecember 19, 2023 | investorplace.comKNW Stock Earnings: Know Labs Reported Results for Q4 2023December 19, 2023 | msn.comKnow Labs GAAP EPS of -$0.41December 19, 2023 | finance.yahoo.comKnow Labs, Inc. Reports Fourth Quarter and Fiscal Year 2023 ResultsDecember 11, 2023 | finance.yahoo.comKnow Labs, Inc. to Host Review of Fiscal Year 2023 Results on December 19, 2023November 8, 2023 | finance.yahoo.comKnow Labs Expands Board of DirectorsSeptember 27, 2023 | news.yahoo.comClinic, lab expansion to get 'dirty'September 27, 2023 | benzinga.comWhy Know Labs (KNW) Stock Hit A New 52-Week Low TodaySeptember 27, 2023 | msn.comWhy Is Know Labs (KNW) Stock Down 37% Today?September 27, 2023 | finance.yahoo.comKnow Labs, Inc. Announces Pricing of $7 Million Public Offering of Common StockSee More Headlines Receive KNW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Know Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/14/2024Today3/28/2024Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorBusiness Services Industry Measuring & controlling devices, not elsewhere classified Sub-IndustryN/A Current SymbolNYSEAMERICAN:KNW CUSIPN/A CIKN/A Webwww.knowlabs.co Phone(206) 903-1351Fax206-826-0451Employees12Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.37) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-15,290,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-416.36% Return on Assets-152.02% Debt Debt-to-Equity RatioN/A Current Ratio1.27 Quick Ratio1.27 Sales & Book Value Annual Sales$4.36 million Price / Sales11.75 Cash FlowN/A Price / Cash FlowN/A Book Value$0.05 per share Price / Book12.60Miscellaneous Outstanding Shares81,350,000Free Float70,202,000Market Cap$51.25 million OptionableNot Optionable Beta1.64 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Ronald P. Erickson J.D. (Age 80)Founder, CEO, Treasurer & Chairman Comp: $544.97kMr. Peter Joseph ConleyCFO & Senior VP of Intellectual PropertyMs. Jessica English (Age 38)Chief Marketing Officer Dr. James H. Anderson Jr.M.D., Chief Medical Officer and Chairman of Medical, Scientific & Regulatory Advisory BoardMr. Steven T. KentChief Product OfficerMr. Leonardo Trautwein (Age 42)Chief Commercial Officer Jordyn HujarChief of StaffMore ExecutivesKey CompetitorsOwletNYSE:OWLTAutoscope TechnologiesNASDAQ:AATCGivBuxOTCMKTS:GBUXHudson GlobalNASDAQ:HSONGorilla Technology GroupNASDAQ:GRRRView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Bought 15,790 shares on 3/11/2024Ownership: 0.612%Citadel Advisors LLCBought 151,001 shares on 2/15/2024Ownership: 0.186%Northern Trust CorpBought 21,823 shares on 2/13/2024Ownership: 0.124%Callan Capital LLCBought 200,000 shares on 2/2/2024Ownership: 0.455%Ichiro John Paul TakesakoSold 8,500 sharesTotal: $7,395.00 ($0.87/share)View All Insider TransactionsView All Institutional Transactions KNW Stock Analysis - Frequently Asked Questions Are investors shorting Know Labs? Know Labs saw a increase in short interest in February. As of February 29th, there was short interest totaling 330,400 shares, an increase of 41.1% from the February 14th total of 234,100 shares. Based on an average trading volume of 210,700 shares, the short-interest ratio is currently 1.6 days. Currently, 0.6% of the company's stock are short sold. View Know Labs' Short Interest. How were Know Labs' earnings last quarter? Know Labs, Inc. (NYSEAMERICAN:KNW) released its quarterly earnings data on Wednesday, February, 14th. The company reported ($0.04) earnings per share for the quarter. Who are Know Labs' major shareholders? Know Labs' stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (0.61%), Callan Capital LLC (0.45%), Citadel Advisors LLC (0.19%) and Northern Trust Corp (0.12%). Insiders that own company stock include Ichiro John Paul Takesako, Jessica English, Leonardo Mouta Trautwein, Ronald P Erickson and William Arthur Owens. View institutional ownership trends. How do I buy shares of Know Labs? Shares of KNW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEAMERICAN:KNW) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThe 3rd Revolution in WarfareWeiss RatingsIs AI Energy Really 4 Million Times More Powerful Than Oil? (Surprising Answer)Banyan Hill PublishingAI to Meet the Same Fate as EVs? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Know Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.